Study to Evaluate the Interest of Qutenza in Patients With Head and Neck Cancer in Remission and With Sequelae Neuropathic Pain.

NCT04704453 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: Capsaïcin patch (Qutenza®)
DRUG: Amitriptyline (Laroxyl®)

Sponsor

Institut Claudius Regaud